Workflow
Space - based biotechnology
icon
Search documents
Truist Upgrades Redwire (RDW) to Buy and Raises Price Target to $15
Yahoo Finance· 2026-03-18 16:56
Core Insights - Redwire Corporation (NYSE:RDW) is recognized as one of the top 10 space exploration stocks to buy according to analysts [1] Group 1: Analyst Upgrades - Truist upgraded Redwire Corporation's rating from Hold to Buy and raised the price target from $13 to $15, citing an improving program mix and development progress that may moderate annual cost charges [2] - The firm highlighted attainable targets for 2026 set by the new CFO, Chris Edmunds, and the Golden Dome awards as significant near-term catalysts for backlog growth [2] Group 2: Recent Developments - Redwire Corporation received an additional $4 million from NASA to expand drug development research on the International Space Station, part of a broader $25 million, five-year contract aimed at advancing space-based biotechnology [3] - The funding will support the growth of high-quality protein crystals in microgravity using Redwire's PIL-BOX technology, which is intended to aid treatments for cancer, osteoporosis, and obesity [3] Group 3: Company Overview - Founded in 2020, Redwire Corporation is an integrated space and defense technology company that provides mission-critical systems, including roll-out solar arrays and in-space manufacturing [4]